274. Osteogenesis Imperfecta Clinical trials / Disease details

Clinical trials : 87 / Drugs : 103 - (DrugBank : 20) / Drug target genes : 14 - Drug target pathways : 76

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000010615	2013/04/30	30/04/2013	Clinical study on efficacy of alendronateinfusion for pediatric osteogenesis imperfecta (including s ...	Clinical study on efficacy of alendronateinfusion for pediatric osteogenesis imperfecta (including s ...	osteogenesis imperfecta	Eighteen micrograms (2 ml)/kg of alendronatewill be infused in 1 hour every 4 weeks. The study durat ...	Tohoku University School of Medicine, Department of Pediatrics	NULL	Complete: follow-up continuing	Not applicable	15years-old	Male and Female	10	Not applicable	Japan
2	NCT02303873 (ClinicalTrials.gov)	March 2007	19/11/2014	Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta	Efficacy and Safety of Alendronatein Chinese Children or Adolescents With Osteogenesis Imperfecta: a ...	Osteogenesis Imperfecta	Drug: Alendronate	Peking Union Medical College Hospital	National Natural Science Foundation of China	Completed	N/A	18 Years	Both	99	Phase 4	NULL
3	NCT00159419 (ClinicalTrials.gov)	August 1999	7/9/2005	Bisphosphonate Therapy for Osteogenesis Imperfecta	Bisphosphonate Therapy for Osteogenesis Imperfecta	Osteogenesis Imperfecta;Osteoporosis;Paget Disease of Bone	Drug: Alendronate;Drug: Pamidronate	Indiana University School of Medicine	NULL	Completed	3 Years	21 Years	All	18	Phase 4	United States

First Previous1Next Last